Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 133.04 |
| Open | 131.94 |
| Bid | 131.31 x 800 |
| Ask | 131.74 x 1200 |
| Day's range | 130.85 - 132.09 |
| 52-week range | 75.56 - 138.28 |
| Volume | |
| Avg. volume | 4,615,383 |
| Market cap | 588.393B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 45.64 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.37 (1.03%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
- Zacks
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.
- Zacks
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
© 2024 Yahoo. All rights reserved.